other

Updated:

The Philadelphia Pediatric Medical Device Consortium

The Philadelphia Pediatric Medical Device Consortium operates as a collaboration hub for pediatric device innovation, drawing on local expertise from the...

The Philadelphia Pediatric Medical Device Consortium

The Philadelphia Pediatric Medical Device Consortium operates as a collaboration hub for pediatric device innovation, drawing on local expertise from the Philadelphia region. Its founding appears tied to an effort to address the lack of pediatric-specific medical devices, a gap long noted by the US Food and Drug Administration and pediatric surgeons. The consortium functions as an incubator and network, connecting clinicians with engineers and business development resources. Strategy centers on designing and prototyping devices for children, covering areas such as surgical instruments, respiratory support, and implanted technologies. The consortium likely partners with academic medical centers, including Children's Hospital of Philadelphia, and with engineering programs at universities in the region. It supports projects from concept through regulatory clearance, aiming for clinical adoption. Team composition includes medical professionals, device designers, and regulatory consultants, though specific numbers and named principals are not publicly recorded. The consortium may also collaborate with the US FDA's Pediatric Device Consortia Grant Program, which funds initiatives that accelerate pediatric device development. No recent operational events or funding rounds are documented in public sources. A structural differentiator is the consortium model itself, which pools institutional expertise rather than operating as a venture fund or individual company. This structure allows risk-sharing and regulatory guidance for multiple device projects simultaneously. The consortium's success depends on maintaining cross-disciplinary cooperation in a niche medtech space.

General information

Firm type

other

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Corporate office

United States

Sector focus

Healthcare ServicesMedical Devices

Frequently asked questions

What types of medical devices does the consortium focus on?

The consortium targets devices specifically for pediatric patients, including surgical tools, respiratory aids, and implantable technologies. Its scope covers any device where adult designs are ill-suited for children's anatomy (per FDA Pediatric Device Consortia program descriptions).

How does the consortium fund its projects?

Funding likely comes from a combination of federal grants, particularly the FDA's Pediatric Device Consortia Grant Program, and university partnerships. Individual projects may also seek venture capital or philanthropic support once prototypes mature (per public record).

Does the consortium work with Children's Hospital of Philadelphia (CHOP)?

Given the Philadelphia location and pediatric focus, CHOP is a probable collaborator, though the consortium's website does not confirm specific partnerships. The hospital is a major pediatric research center in the region (per CHOP's own descriptions).

What is the regulatory pathway for devices developed by the consortium?

Devices typically go through FDA premarket notification (510(k)) or premarket approval (PMA), depending on risk. The consortium's structure helps navigate these requirements by providing regulatory expertise shared across projects (per FDA Pediatric Device Consortia guidelines).

Who are the key individuals leading the consortium?

Publicly available information does not name specific principals. The consortium is a collaborative entity, and leadership likely rotates among participating hospitals and engineering faculty. This is a limitation of the available public record.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo